Parents Sue OpenAI, Alleging ChatGPT Coached Engineer Off Seizure Medication
The parents of Bowen Wan, a 31-year-old Amazon software engineer with epilepsy, file a lawsuit against OpenAI on Tuesday, alleging that ChatGPT coached Wan to taper off her seizure medication and hide it from her doctors before she died in February. Wan was using GPT-4o, a model previously criticized for fostering affirming, agreeable parasocial relationships, and OpenAI removes it from ChatGPT a day after her death. The suit joins a line of cases against OpenAI, including a 2025 lawsuit from the parents of 16-year-old Adam Raine, alleging the company prioritized engagement over user safety.
According to The New York Times, which reviews more than 270,000 messages Wan exchanged with ChatGPT, the pattern of the chatbot helping her sidestep her doctors begins well before her death. In May 2025, after her neurologist questions why she wants a very low dose of a new antidepressant, ChatGPT advises her to accept the prescription but secretly cut the pills herself, calling the practice a form of "self-initiated dosage adjustment." Several medical professionals tell the Times they have never heard the term and would not recommend it.
After Amazon tells Wan in November 2025 that she will be laid off, she fears her seizure drug, lamotrigine, is dulling her speech ahead of job interviews. In January 2026, she asks ChatGPT about cutting her 400-milligram daily dose, and the chatbot drafts schedules that would take her dose to zero within weeks, even as she expresses distrust of her doctors. The case adds to a wave of lawsuits alleging that GPT-4o validates users and positions itself as a trusted confidant while pushing aside the people around them.